Vasco Bravo-Filho

952 total citations
25 papers, 264 citations indexed

About

Vasco Bravo-Filho is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vasco Bravo-Filho has authored 25 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vasco Bravo-Filho's work include Retinal Diseases and Treatments (7 papers), Ocular Oncology and Treatments (7 papers) and Retinal and Optic Conditions (5 papers). Vasco Bravo-Filho is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Ocular Oncology and Treatments (7 papers) and Retinal and Optic Conditions (5 papers). Vasco Bravo-Filho collaborates with scholars based in Canada, Brazil and United States. Vasco Bravo-Filho's co-authors include Miguel N. Burnier, Pablo Zoroquiaín, Maurício Maia, Camila V. Ventura, Rubens Belfort, Patrick Logan, Adriana L. Gois, Liana O. Ventura, Tiago Eugênio Faria e Arantes and João Rafael de Oliveira Dias and has published in prestigious journals such as Progress in Retinal and Eye Research, Investigative Ophthalmology & Visual Science and American Journal of Clinical Pathology.

In The Last Decade

Vasco Bravo-Filho

24 papers receiving 252 citations

Peers

Vasco Bravo-Filho
J L Goyal India
H. Bouguila Tunisia
Ian R. Gorovoy United States
Shelley Day United States
Reem H. ElSheikh United States
İsmet Durak Türkiye
Praneetha Thulasi United States
J L Goyal India
Vasco Bravo-Filho
Citations per year, relative to Vasco Bravo-Filho Vasco Bravo-Filho (= 1×) peers J L Goyal

Countries citing papers authored by Vasco Bravo-Filho

Since Specialization
Citations

This map shows the geographic impact of Vasco Bravo-Filho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasco Bravo-Filho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasco Bravo-Filho more than expected).

Fields of papers citing papers by Vasco Bravo-Filho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasco Bravo-Filho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasco Bravo-Filho. The network helps show where Vasco Bravo-Filho may publish in the future.

Co-authorship network of co-authors of Vasco Bravo-Filho

This figure shows the co-authorship network connecting the top 25 collaborators of Vasco Bravo-Filho. A scholar is included among the top collaborators of Vasco Bravo-Filho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasco Bravo-Filho. Vasco Bravo-Filho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lira, Rodrigo Pessoa Cavalcanti, et al.. (2021). Optical coherence tomography angiography: microvascular alterations in diabetic eyes without diabetic retinopathy. Arquivos Brasileiros de Oftalmologia. 84(2). 149–157. 13 indexed citations
2.
Tsering, Thupten, Miguel N. Burnier, Vasco Bravo-Filho, et al.. (2020). Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines. Ocular Oncology and Pathology. 6(6). 442–455. 5 indexed citations
3.
Bravo-Filho, Vasco, Patrick Logan, Pablo Zoroquiaín, et al.. (2019). Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells. Arquivos Brasileiros de Oftalmologia. 82(1). 38–44. 1 indexed citations
4.
Dias, João Rafael de Oliveira, Camila V. Ventura, Bruno de Paula Freitas, et al.. (2018). Zika and the Eye: Pieces of a Puzzle. Progress in Retinal and Eye Research. 66. 85–106. 24 indexed citations
5.
Bravo-Filho, Vasco, et al.. (2017). Blue-light filtering alters angiogenic signaling in human retinal pigmented epithelial cells culture model. BMC Ophthalmology. 17(1). 198–198. 19 indexed citations
6.
Alemán, Tomás S., Camila V. Ventura, Leona Serrano, et al.. (2017). Quantitative Assessment of Microstructural Changes of the Retina in Infants With Congenital Zika Syndrome. JAMA Ophthalmology. 135(10). 1069–1069. 27 indexed citations
7.
Zoroquiaín, Pablo, et al.. (2016). Analysis of HSP90 Expression Is Valuable in the Differential Diagnosis of Ocular Surface Squamous Lesions. American Journal of Clinical Pathology. 145(3). 385–392. 9 indexed citations
8.
Zoroquiaín, Pablo, et al.. (2016). High frequency of squamous intraepithelial neoplasia in pterygium related to low ultraviolet light exposure. Saudi Journal of Ophthalmology. 30(2). 113–116. 17 indexed citations
9.
Zoroquiaín, Pablo, Vasco Bravo-Filho, John Chen, et al.. (2016). Pericyte Status in Routinely Discarded Vitrectomy Samples May Be an Early Marker of Diabetic Retinopathy. Ophthalmic Research. 56(2). 79–84.
10.
Ventura, Camila V., Liana O. Ventura, Vasco Bravo-Filho, et al.. (2016). Optical Coherence Tomography of Retinal Lesions in Infants With Congenital Zika Syndrome. JAMA Ophthalmology. 134(12). 1420–1420. 43 indexed citations
11.
Neto, Carlos Augusto Moreira, et al.. (2016). Pretreatment of RPE Cells with Lutein Can Mitigate Bevacizumab-Induced Increases in Angiogenin and bFGF. Ophthalmic Research. 57(1). 48–53. 8 indexed citations
12.
Bravo-Filho, Vasco, et al.. (2015). Evaluating the in vivo efficacy of a novel first in class drug for the treatment of primary uveal melanoma. Investigative Ophthalmology & Visual Science. 56(7). 1291–1291. 1 indexed citations
13.
Zoroquiaín, Pablo, et al.. (2015). Diagnosing Pathological Prognostic Factors in Retinoblastoma: Correlation between Traditional Microscopy and Digital Slides. Ocular Oncology and Pathology. 1(4). 259–265. 3 indexed citations
14.
Kobalka, Peter, Pablo Zoroquiaín, Francisco C. Ceballos, et al.. (2014). Pancreas and Biliary Tree. Modern Pathology. 27. 445–458. 1 indexed citations
15.
Bravo-Filho, Vasco, et al.. (2014). Expression of focal adhesion kinase in uveal melanoma and the effects of Hsp90 inhibition by 17-AAG. Pathology - Research and Practice. 210(11). 739–745. 6 indexed citations
16.
Zoroquiaín, Pablo, et al.. (2014). HISTOPATHOLOGICAL FEATURES OF VITREOUS SAMPLES IN DIABETIC PATIENTS. Investigative Ophthalmology & Visual Science. 55(13). 4927–4927. 1 indexed citations
17.
Bravo-Filho, Vasco, et al.. (2014). MACULAR AND PERIPAPILLARY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY CHANGES IN SICKLE CELL RETINOPATHY. Retina. 35(2). 257–263. 37 indexed citations
18.
Maloney, S., Bruno F. Fernandes, Rafaella C. Penteado, et al.. (2013). Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma. Journal of Ophthalmology. 2013. 1–4. 1 indexed citations
19.
Bravo-Filho, Vasco, et al.. (2012). Impacto do déficit visual na qualidade de vida em idosos usuários do sistema único de saúde vivendo no sertão de Pernambuco. Arquivos Brasileiros de Oftalmologia. 75(3). 161–165. 13 indexed citations
20.
Cesare, Sebastian Di, Jean‐Claude Marshall, Bruno F. Fernandes, et al.. (2007). In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines. Cancer Cell International. 7(1). 17–17. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026